Department of Cancer Biology, Thomas Jefferson University, 233 S. 10 Street, Philadelphia, PA 19107, USA.
Am J Pathol. 2010 Mar;176(3):1058-64. doi: 10.2353/ajpath.2010.090664. Epub 2010 Jan 14.
The discovery of microRNAs as a novel class of gene expression regulators has led to a new strategy for disease diagnostics and therapeutics. Cell cycle, cell proliferation, and tumorigenesis are all regulated by microRNAs. Several general principles linking microRNAs and cancer have been recently reviewed; therefore, the current review focuses specifically on the perspective of microRNAs in control of cell cycle, stem cells, and heterotypic signaling, as well as the role of these processes in breast cancer. Altered abundance of cell cycle regulation proteins and aberrant expression of microRNAs frequently coexist in human breast cancers. Altered microRNA expression in breast cancer cell lines is associated with altered cell cycle progression and cell proliferation. Indeed, recent studies have demonstrated a causal role for microRNA in governing breast tumor suppression or collaborative oncogenesis. This review summarizes the current understanding of the role for microRNA in regulating the cell cycle and summarizes the evidence for aberrant microRNA expression in breast cancer. The new evidence for microRNA regulation by annotated genes and the involvement of microRNA in breast cancer metastasis are discussed, as is the potential for microRNA to improve breast cancer diagnosis and therapy.
microRNAs 的发现作为一类新的基因表达调控因子,为疾病的诊断和治疗提供了新策略。细胞周期、细胞增殖和肿瘤发生都受到 microRNAs 的调节。最近已经综述了将 microRNAs 与癌症联系起来的一些一般原则;因此,本综述特别关注 microRNAs 在控制细胞周期、干细胞和异型信号以及这些过程在乳腺癌中的作用的观点。细胞周期调控蛋白的丰度改变和 microRNAs 的异常表达经常共存于人类乳腺癌中。乳腺癌细胞系中 microRNA 的表达改变与细胞周期进程和细胞增殖的改变有关。事实上,最近的研究表明 microRNA 在控制乳腺肿瘤抑制或协同致癌中起因果作用。本综述总结了 microRNA 在调节细胞周期中的作用的现有认识,并总结了 microRNA 在乳腺癌中异常表达的证据。讨论了注释基因对 microRNA 调节的新证据以及 microRNA 参与乳腺癌转移的情况,还讨论了 microRNA 改善乳腺癌诊断和治疗的潜力。